Speaker In-Kind

The following companies with speakers on one or more Keystone Symposia meeting programs have generously agreed to forego reimbursements for speaker travel and lodging expenses.



  • Adimab, Inc.
  • AFFiRiS AG
  • Almirall, S.A.
  • Amgen Inc.
  • Arcturus Therapeutics, Inc.
  • Arcus Biosciences, Inc.
  • AstraZeneca
  • Biogen
  • BioVersys AG
  • bluebird bio
  • Boehringer Ingelheim Pharmaceuticals, Inc.
  • Bristol-Myers Squibb Company
  • Burke Bioventures
  • Celgene Corporation
  • Celularity Inc.
  • Chiesi Farmaceutici
  • Circuit Therapeutics
  • Complexa Inc.
  • CytomX Therapeutics, Inc.
  • Denali Therapeutics Inc.
  • Dynavax Technologies Corporation
  • Elektra Labs
  • Eli Lilly and Company
  • Eurofins DiscoverX
  • Forty Seven, Inc.
  • Genentech, Inc.
  • Genmab B.V.
  • Gilead Sciences, Inc.
  • GlaxoSmithKline
  • GrĂ¼nenthal GmbH
  • Helix
  • Intarcia Therapeutics, Inc.
  • Ionis Pharmaceuticals, Inc.
  • Janssen R&D: Pharmaceutical Companies of Johnson & Johnson
  • Janssen Vaccines & Prevention BV
  • Jounce Therapeutics, Inc.
  • Koneksa Health
  • Kyn Therapeutics
  • Lundbeck
  • Merck & Co., Inc.
  • Microsoft Corporation
  • Mindstrong Health
  • Moderna
  • Nektar Therapeutics
  • Novartis Institutes for BioMedical Research
  • NovImmune SA
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Regeneron Genetics Center, LLC
  • Regeneron Pharmaceuticals, Inc.
  • Roche
  • Sirenas
  • Spark Therapeutics
  • Takeda Pharmaceutical Company Limited
  • Translate Bio
  • Viela Bio
  • Xencor, Inc.